TABLE 2.
Distribution of N-acetyltransferase 2 (NAT2) alleles and acetylator genotypes in inflammatory bowel disease (IBD) patients and in healthy controls (con)
|
Alleles |
Acetylator genotypes |
|||||
|---|---|---|---|---|---|---|
| NAT2*4 n (%) | NAT2*5B n (%) | NAT2*6A n (%) | NAT2*7B n (%) | Fast n (%) | Slow n (%) | |
| Con (n=109) | 130 (59.6) | 12 (5.5) | 51 (23.4) | 25 (11.5) | 86 (78.9) | 23 (21.1) |
| IBD (n=101) | 116 (57.4) | 9 (4.5) | 49 (24.3) | 28 (13.9) | 79 (78.2) | 22 (21.8) |
| UC (n=84) | 98 (58.3) | 8 (4.8) | 40 (23.8) | 22 (13.1) | 68 (80.9) | 16 (19.1) |
| CD (n=17) | 18 (52.9) | 1 (2.9) | 9 (26.5) | 6 (17.6) | 11 (64.7) | 6 (35.3) |
CD Crohn’s disease; UC Ulcerative colitis